Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,271,000 | 8,860,000 | 7,007,000 | 4,674,000 | 13,023,000 |
| Marketable Securities | 2,693,000 | 625,000 | 770,000 | 773,000 | 839,000 |
| Receivables | 8,975,000 | 8,802,000 | 8,358,000 | 8,180,000 | 8,275,000 |
| Inventories | 6,956,000 | 6,867,000 | 6,255,000 | 6,226,000 | 6,093,000 |
| Other current assets | 3,668,000 | 3,054,000 | 2,541,000 | 2,992,000 | 9,331,000 |
| TOTAL | $35,563,000 | $28,208,000 | $24,931,000 | $22,845,000 | $37,561,000 |
| Non-Current Assets | |||||
| PPE Net | 15,696,000 | 16,464,000 | 15,641,000 | 15,982,000 | 15,983,000 |
| Investments And Advances | 10,697,000 | 17,613,000 | 16,500,000 | 17,780,000 | 10,152,000 |
| Intangibles | 74,013,000 | 61,747,000 | 62,320,000 | 65,391,000 | 53,143,000 |
| Other Non-Current Assets | 9,594,000 | 9,047,000 | 10,732,000 | 9,558,000 | 8,548,000 |
| TOTAL | $110,000,000 | $104,871,000 | $105,193,000 | $108,711,000 | $87,826,000 |
| Total Assets | $145,563,000 | $133,079,000 | $130,124,000 | $131,556,000 | $125,387,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,678,000 | 5,308,000 | 5,905,000 | 5,604,000 | 6,612,000 |
| Accounts payable and accrued liabilities | 5,556,000 | 5,169,000 | 4,873,000 | 5,668,000 | 5,419,000 |
| Other current liabilities | 12,335,000 | 11,203,000 | 9,828,000 | 10,719,000 | 10,448,000 |
| TOTAL | $29,607,000 | $23,403,000 | $22,209,000 | $23,708,000 | $26,973,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,470,000 | 23,224,000 | 17,897,000 | 16,327,000 | 13,799,000 |
| Other Non-Current Liabilities | 7,316,000 | 7,057,000 | 8,484,000 | 8,033,000 | 7,602,000 |
| TOTAL | $37,264,000 | $35,449,000 | $33,024,000 | $30,726,000 | $27,570,000 |
| Total Liabilities | $66,871,000 | $58,852,000 | $55,233,000 | $54,434,000 | $54,543,000 |
| Shareholders' Equity | |||||
| Common Shares | 944,000 | 969,000 | 972,000 | 991,000 | 1,001,000 |
| Retained earnings | 77,739,000 | 73,299,000 | 73,936,000 | 76,156,000 | 69,868,000 |
| Other shareholders' equity | 78,000 | 59,000 | 59,000 | 76,000 | 78,000 |
| TOTAL | $78,692,000 | $74,227,000 | $74,891,000 | $77,122,000 | $70,844,000 |
| Total Liabilities And Equity | $145,563,000 | $133,079,000 | $130,124,000 | $131,556,000 | $125,387,000 |